SNDY, SYMD, EXCS, MCGI and WRIT are the Daily Market Movers for March 29th from OTCPicks.com
OTCPicks.com Presents Today’s Daily Market Movers: Solos Endoscopy Inc. (OTC: SNDY), SyntheMed Inc. (OTCBB: SYMD), Execute Sports Inc. (OTCBB: EXCS), MedCareers Group Inc. (OTCQB: MCGI) and Writers’ Group Film Corp. (OTCQB: WRIT).
(EMAILWIRE.COM, March 29, 2011 )
SYNTHEMED INCORPORATED (OTCBB: SYMD) "Up 80.00% in morning trading"
SyntheMed, Inc., a biomaterials company, engages in the development and commercialization of medical devices for therapeutic applications. It offers surgical implants designed to prevent or reduce the formation of adhesions/scar tissue following a range of surgical procedures. The company's lead product includes REPEL-CV, a bioresorbable film designed to be placed over the surface of the heart at the conclusion of surgery to reduce the formation of post-operative adhesions. SyntheMed offers products based on the proprietary, bioresorbable polymer technology. Its products also include REPEL-AFIB, which reduces the patient risk associated with atrial fibrillation; RESOLVE that prevents or reduces post-operative surgical adhesions in gynecological and general abdominal surgery; and RELIEVE for preventing or reducing post-operative surgical adhesions in orthopedic and spinal surgery. The company, formerly known as Life Medical Sciences, Inc., was founded in 1990 and is headquartered in Iselin, New Jersey.
http://www.emailwire.com/release/60542-SNDY-SYMD-EXCS-MCGI-and-WRIT-are-the-Daily-Market-Movers-for-March-29th-from-OTCPickscom.html
OTCPicks.com Presents Today’s Daily Market Movers: Solos Endoscopy Inc. (OTC: SNDY), SyntheMed Inc. (OTCBB: SYMD), Execute Sports Inc. (OTCBB: EXCS), MedCareers Group Inc. (OTCQB: MCGI) and Writers’ Group Film Corp. (OTCQB: WRIT).
(EMAILWIRE.COM, March 29, 2011 )
SYNTHEMED INCORPORATED (OTCBB: SYMD) "Up 80.00% in morning trading"
SyntheMed, Inc., a biomaterials company, engages in the development and commercialization of medical devices for therapeutic applications. It offers surgical implants designed to prevent or reduce the formation of adhesions/scar tissue following a range of surgical procedures. The company's lead product includes REPEL-CV, a bioresorbable film designed to be placed over the surface of the heart at the conclusion of surgery to reduce the formation of post-operative adhesions. SyntheMed offers products based on the proprietary, bioresorbable polymer technology. Its products also include REPEL-AFIB, which reduces the patient risk associated with atrial fibrillation; RESOLVE that prevents or reduces post-operative surgical adhesions in gynecological and general abdominal surgery; and RELIEVE for preventing or reducing post-operative surgical adhesions in orthopedic and spinal surgery. The company, formerly known as Life Medical Sciences, Inc., was founded in 1990 and is headquartered in Iselin, New Jersey.
http://www.emailwire.com/release/60542-SNDY-SYMD-EXCS-MCGI-and-WRIT-are-the-Daily-Market-Movers-for-March-29th-from-OTCPickscom.html
No comments:
Post a Comment